PCI Biotech Holding ASA (PCIB) — Cash Flow Quality Index
Latest as of March 2020:
-5.17x
PCI Biotech Holding ASA (PCIB) has a Cash Flow Quality Index of -5.17x as of March 2020. Operating cash flow of Nkr-22.87 Million is below net income of Nkr4.43 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore PCIB total asset value for the complete picture of this company's asset base.
Cash Flow Quality Index
-5.17x
Operating CF / Net Income
Operating Cash Flow
Nkr-22.87 Million
NOK
Net Income
Nkr4.43 Million
NOK
Data as of
Mar 2020
Most recent filing
Annual Cash Flow Quality Index for PCI Biotech Holding ASA (None–None)
Year-by-year earnings quality comparison for PCI Biotech Holding ASA. For live market cap and the full company financial profile, see market value of PCI Biotech Holding ASA.
| Year | Quality Index | Operating CF (NOK) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.